Science
Mechanism of Action
PABA functions primarily as a UVB absorber, effectively intercepting radiation between 290 and 320 nm. Its chemical architecture, characterized by para-positioned amino and carboxyl groups, facilitates electron delocalization, enabling electrons to transition to a higher energy state upon light absorption. Additionally, PABA possesses local anesthetic capabilities by modulating sodium influx into nerve cells, thereby inhibiting neural conduction within sensory nerves and reducing pain signal transmission.
Research
Clinical Evidence
Low confidenceN/A
Key findings
- 01 Oral administration of 12g PABA daily was observed to significantly slow the progression of Peyronie's disease, though it did not reduce preexisting plaque. The efficacy for other conditions like scleroderma, male infertility, and vitiligo relies on older studies lacking rigorous controls and strong scientific backing.
- 02 PABA-terminated dendrimers, at concentrations above 20 μM, demonstrated enhanced scavenging of radicals and radical cations in vitro. They fully suppressed human melanoma cell line proliferation at 100 μM and reduced it between 20–100 μM. While generating a small amount of reactive oxygen species at 20 μM, human fibroblast and mouse cerebellar granule cells remained intact.
Transparency
Dusting Analysis
PABA has been deemed unsafe and not Generally Recognized As Safe and Effective (GRASE) by the FDA for sunscreen use since 2019, and its use is prohibited in Europe for cosmetic applications. Any concentration of PABA in a cosmetic product would therefore constitute a regulatory red flag and safety concern.
The Formula
Formulation
Stability
PABA is susceptible to photodegradation through an O2-mediated pathway. Notably, PABA derivatives, such as Ethylhexyl Dimethyl PABA, are known to be photo unstable, experiencing a 10% loss of efficacy within 20 minutes and 50% within 85 minutes of light exposure.
Conflicts
- Sulfonamide antibiotics (decreases antibiotic effectiveness, primarily oral)
- Cortisone (might decrease the rate of cortisone breakdown, primarily oral)
- Alcohol-based formulations (can induce burning or stinging sensations in individuals with PABA allergies)
Safety
Safety Profile
PABA presents a high risk for adverse reactions, particularly in individuals with sensitive skin. It is frequently associated with allergic manifestations such as contact dermatitis, skin rashes, burning, stinging, and photosensitivity. Additional concerns include general skin irritation, dry skin, and potential yellow staining of clothing. Animal studies suggest that PABA may increase the risk of cellular UV damage and has been implicated in the emergence of skin cancer. Furthermore, some research indicates a potential to interfere with hormone function, disrupt thyroid activity, and elevate the risk of breast cancer. PABA has also been linked to increased hyperpigmentation and premature aging, mediated by the formation of free radicals upon sun exposure.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Due to its extensive list of safety concerns, high sensitization risk, and regulatory prohibitions by the FDA and in Europe, PABA should be completely avoided in contemporary skincare formulations.
Related
Similar Ingredients
Finding similar ingredients…